Company profile
FutureWorld Corp.
OTC: FWDG · Healthcare · Drug Manufacturers - Specialty & Generic
#1079 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 5GM —SS 38
v0.1 · 25/100 weight · pillars only
↑ balance-sheet leverage, Piotroski F · ↓ disclosure history, filing timeliness
Methodology →Revenue TTM
$195.9k
Rev growth YoY (TTM)
-153.6%
Net income (FY)
-$1.4M
Employees
8
as of 2026-08-27
Market cap
$263.6k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$54.0k$54.0k2015
Net income-$1.4M-$1.4M2015
Operating income-$974.9k-$974.9k2015
Total assets$35.4M$35.4M2015
Liabilities$1.7M$1.7M2015
Equity$33.7M$33.7M2015
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is FutureWorld Corp.’s revenue?
FutureWorld Corp. booked $54.0k in FY2015 revenue — among the slowest-growing Healthcare companies we track, at a -2603.8% net margin.
Peers · Healthcare
Therma Bright Inc.23DGain Therapeutics, Inc.36DHCW Biologics Inc.31DNatural Health Farm Holdings Inc.——INmune Bio, Inc.41DMultiCell Technologies, Inc.——Neighbors
Pinellas →Key facts
CEOSaeed Talari
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSaint Petersburg, FL
ExchangeOTC: FWDG
Employees8
IPO date2011-09-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.